Boston Criteria v2.0 (cerebral amyloid angiopathy)
Boston Criteria v2.0 (cerebral amyloid angiopathy) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
Open the Boston Criteria v2.0 (cerebral amyloid angiopathy) → Runs in your browser. No signup, no tracking.
What this is
Boston Criteria v2.0 (cerebral amyloid angiopathy) is one of 230 deterministic tools in Sophie Well's Clinical Scoring & Risk group. Boston Criteria v2.0 (cerebral amyloid angiopathy) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
When to use it
Use this tool when you need a quick, citable reference. Every calculation runs entirely in your browser - no inputs leave your device, no account is required, no AI is involved. The site enforces a strict Content Security Policy and ships no analytics or third-party CDN.
References
Charidimou A, Boulouis G, Frosch MP, et al. The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study. Lancet Neurol. 2022;21(8):714-725. Read the source ↗
Worked example: Probable CAA: >= 2 strictly lobar hemorrhagic lesions, with a compatible presentation, age 50 or older, and no deep hemorrhagic lesion.
Sophie Well is a reference and educational tool. Not medical, legal, or financial advice. Does not replace clinician judgment, professional billing review, or legal counsel.